Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome

NCT00933686 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

113

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: Saizen®
DRUG: Placebo and Saizen®

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]